Alk-Abello AS (AKBLF)
24.60
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Alk-Abello Shareholders Equity (Quarterly): 706.13M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 706.13M |
March 31, 2024 | 678.43M |
December 31, 2023 | 660.26M |
September 30, 2023 | 614.81M |
June 30, 2023 | 610.57M |
March 31, 2023 | 602.81M |
December 31, 2022 | 573.98M |
September 30, 2022 | 521.82M |
June 30, 2022 | 531.55M |
March 31, 2022 | 548.63M |
December 31, 2021 | 529.78M |
September 30, 2021 | 517.02M |
June 30, 2021 | 519.94M |
March 31, 2021 | 523.76M |
December 31, 2020 | 521.14M |
September 30, 2020 | 505.03M |
June 30, 2020 | 489.22M |
March 31, 2020 | 484.26M |
December 31, 2019 | 476.15M |
September 30, 2019 | 467.90M |
June 30, 2019 | 483.39M |
March 31, 2019 | 495.32M |
December 31, 2018 | 486.99M |
September 30, 2018 | 511.74M |
June 30, 2018 | 512.83M |
Date | Value |
---|---|
March 31, 2018 | 543.41M |
December 31, 2017 | 530.18M |
September 30, 2017 | 436.22M |
June 30, 2017 | 428.72M |
March 31, 2017 | 405.52M |
December 31, 2016 | 408.85M |
September 30, 2016 | 427.12M |
June 30, 2016 | 424.94M |
March 31, 2016 | 419.93M |
December 31, 2015 | 395.06M |
September 30, 2015 | 384.04M |
June 30, 2015 | 373.57M |
March 31, 2015 | 355.18M |
December 31, 2014 | 384.34M |
September 30, 2014 | 399.73M |
June 30, 2014 | 420.42M |
March 31, 2014 | 422.21M |
December 31, 2013 | 416.27M |
September 30, 2013 | 401.48M |
June 30, 2013 | 388.25M |
March 31, 2013 | 386.54M |
December 31, 2012 | 400.03M |
September 30, 2012 | 401.19M |
June 30, 2012 | 381.25M |
March 31, 2012 | 382.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
467.90M
Minimum
Sep 2019
706.13M
Maximum
Jun 2024
554.16M
Average
526.77M
Median
Shareholders Equity (Quarterly) Benchmarks
Genmab AS | 4.446B |
Ascendis Pharma AS | -344.22M |
Galecto Inc | 23.59M |
Evaxion Biotech AS | 1.253M |
IO Biotech Inc | 96.27M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.011B |
Total Liabilities (Quarterly) | 305.19M |
Debt to Equity Ratio | 0.0394 |
Current Ratio | 2.667 |
Net Debt Paydown Yield | 0.11% |